Stem cells may heal lungs of premature babies

Premature babies need extra oxygen and mechanical intervention to breathe but this can damage their lungs, causing a chronic lung disease. A stem cell treatment soon to be tested in clinical trials at The Ottawa Hospital may help heal the lungs of premature babies.

Little Olivia Eberts had oxygen tubes in her nose until after her first birthday. Because she was born prematurely her tiny lungs were underdeveloped and she couldn’t breathe without oxygen. Ironically for Olivia, and many premature babies like her, the oxygen that saved her life also damaged her lungs, causing bronchopulmonary dysplasia (BPD), which is like starting out life with emphysema. This meant she needed to stay on oxygen even longer to help her breathe.

“She was on supplemental oxygen for so long, it was almost part of her identity,” said Jamie Eberts, Olivia’s mother.

Jamie Eberts holding baby Olivia
Jamie Eberts holding baby Olivia

Olivia was born on January 29, 2017, at 23 and a half weeks gestation―or 17 weeks too early. She weighed one pound, two ounces. Her twin brother Liam weighed only a few ounces more than her. Both babies required oxygen and mechanical ventilation to keep them alive and as a result both developed BPD—the most common cause of death in premature babies. Sadly, baby Liam passed away a few weeks after he was born while Olivia remained in the Neonatal Intensive Care Unit (NICU) at The Ottawa Hospital for seven months.

In Canada, 1,000 babies suffer from BPD every year. Often babies with BPD, develop other chronic lung diseases, such as asthma, and many require prolonged oxygen and ventilation. They also have a high incidence of hospital readmissions in the first two years of life. Babies with BPD often have problems in other organs as well, such as the brain or the eyes.

When Olivia was finally discharged, she went home with an oxygen tank. During the first year of her life, Olivia spent more time in hospital than out.

“Even now, a simple flu that put me in bed for a couple of days, put her in hospital and turned into pneumonia. It’s scary,” said Jamie. The doctor told her that with Olivia’s respiratory issues, there would be no guarantee she will ever leave the hospital entirely.’”

“Currently there is no treatment for this disease,” said Dr. Bernard Thébaud, a neonatologist and senior scientist at The Ottawa Hospital.

He hopes to change the outcome for babies, like Olivia, who have BPD.

“In the laboratory, we discovered that a particular type of stem cell can prevent BPD or regenerate newborn lungs,” said Dr. Thébaud, who is also appointed at CHEO and the University of Ottawa. “Our research uses stem cells, isolated from the umbilical cords of healthy newborns, to prevent the lung injury or even to some degree regenerate a damaged lung in the laboratory. We foresee that these stem cells, given during a certain time during the hospital stay of these babies, could prevent the progression of the lung disease.”

Dr. Bernard Thébaud looks at a premature baby in an isolette.
Dr. Bernard Thébaud looks at a premature baby in an isolette.

Dr. Thébaud and his research team are preparing for an early phase clinical trial to test the feasibility and safety of the stem cell treatment on premature babies.

“Stem cell research is incredibly innovative. Here, we have a very promising, emerging therapy that could prevent lung injury but also improve brain development and eye sight,” said Janet Brintnell, Clinical Manager of the NICU who has seen dozens of premature babies suffer from BPD. “It’s amazing when you think of what it may be able to do for the quality of life for the child, for their family, and for our health-care system. It could reduce length of stay, hospital admissions, and reduce long-term outcomes. It could help these little ones lead healthier lives.”

“We are the only ones doing this kind of stem cell research in Canada, and there are only a few other teams in the world that are doing this,” said Dr. Thébaud.

Two years ago, when Olivia was in the NICU, Jamie and her husband Tim met Dr. Thébaud and wished his stem cell treatment could have been available to help heal their babies.

“What’s hard is we think, ‘But if we could’ve signed up for the trial? Would Liam be alive? Would Olivia be suffering?” said Jamie. “Even to this day, if we are asked to put Olivia in the trial as an older candidate, we will.”

Olivia is now a happy, active toddler who loves copying what her older brother Jacob does. Although, she still has BPD, it is increasingly manageable, and she no longer requires supplemental oxygen. Olivia may suffer respiratory illness her entire life but one day, a stem cell treatment developed here in Ottawa could mean that the next generation of babies with BPD won’t.

“Donors are extremely important to allow us to perform this research, especially when it comes to the stage where it matters most: to translate this research into treatment and have clinical trials.” — Dr. Bernard Thébaud, neonatologist

More Stories

Four years after metastatic breast cancer diagnosis, every day is a gift
Jillian O’Connor was 18 weeks pregnant when she was diagnosed with breast cancer and given less than two years to live. In February, she celebrated the fourth birthday of her healthy baby boy and continues to live life to the fullest.
Clinical trial means new options for colorectal cancer patients
Sandy Patenaude participated in a clinical trial of a cancer stem cell inhibitor drug, which successfully prevented her cancer from growing. As a result, doctors are able to determine which patients might benefit from the drug.
Natural killer cells could be immunotherapy game-changer
Scientist discovers other immune cells that have the potential to make immunotherapy treatments work for more people, and more types of cancers.